01 14Servier Canada Inc.
01 22496723
02 22537400
03 22537404
04 22537414
05 22537420
06 22564367
07 22564369
01 14IVABRADINE HYDROCHLORIDE
01 14TABLET
01 22025-02-07
02 82026-02-24
03 42026-10-11
Patent Expiration Date : 2025-02-07
Date Granted : 2010-05-25
Brand Name : LANCORA
Patent Number : 2496723
Filing Date : 2005-02-07
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-02-07
Date Granted : 2010-05-25
Patent Expiration Date : 2026-02-24
Date Granted : 2009-12-15
Brand Name : LANCORA
Patent Number : 2537400
Filing Date : 2006-02-24
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-02-24
Date Granted : 2009-12-15
Patent Expiration Date : 2026-02-24
Date Granted : 2010-04-13
Brand Name : LANCORA
Patent Number : 2537404
Filing Date : 2006-02-24
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-02-24
Date Granted : 2010-04-13
Patent Expiration Date : 2026-02-24
Date Granted : 2010-02-16
Brand Name : LANCORA
Patent Number : 2537414
Filing Date : 2006-02-24
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-02-24
Date Granted : 2010-02-16
Patent Expiration Date : 2026-02-24
Date Granted : 2010-03-30
Brand Name : LANCORA
Patent Number : 2537420
Filing Date : 2006-02-24
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-02-24
Date Granted : 2010-03-30
Patent Expiration Date : 2026-10-11
Date Granted : 2010-05-18
Brand Name : LANCORA
Patent Number : 2564367
Filing Date : 2006-10-11
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-10-11
Date Granted : 2010-05-18
Patent Expiration Date : 2026-10-11
Date Granted : 2010-06-15
Brand Name : LANCORA
Patent Number : 2564369
Filing Date : 2006-10-11
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-10-11
Date Granted : 2010-06-15
Patent Expiration Date : 2025-02-07
Date Granted : 2010-05-25
Brand Name : LANCORA
Patent Number : 2496723
Filing Date : 2005-02-07
Strength per Unit : 7.5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-02-07
Date Granted : 2010-05-25
Patent Expiration Date : 2026-02-24
Date Granted : 2009-12-15
Brand Name : LANCORA
Patent Number : 2537400
Filing Date : 2006-02-24
Strength per Unit : 7.5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-02-24
Date Granted : 2009-12-15
Patent Expiration Date : 2026-02-24
Date Granted : 2010-04-13
Brand Name : LANCORA
Patent Number : 2537404
Filing Date : 2006-02-24
Strength per Unit : 7.5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-02-24
Date Granted : 2010-04-13
